Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015

Ítems similars

• Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome
  per: Busutti, Marco, et al.
  Publicat: (2020)
• Complement and the atypical hemolytic uremic syndrome in children
  per: Loirat, Chantal, et al.
  Publicat: (2008)
• Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis
  per: Aradottir, Sigridur Sunna, et al.
  Publicat: (2021)
• Translational Mini-Review Series on Complement Factor H: Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
  per: Noris, M, et al.
  Publicat: (2008)
• Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated glomerular diseases?
  per: Ankawi, Ghada A, et al.
  Publicat: (2017)